RIPK3 and neoplasm: Whether other ICD forms, including necroptosis (occurring downstream of the receptor-interacting protein kinases RIPK1 and RIPK3)73, can enable tumor cells to generate similar or overlapping sets of NM-neoAg repertoire that may contribute to potentiate anti-tumor immunity54 is a crucial issue to investigate.